Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
出版年份 2020 全文链接
标题
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-11
DOI
10.1007/s10549-020-05914-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
- (2020) Laura M Spring et al. LANCET
- Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
- (2020) Yoo Jung Kim et al. Dermatology and Therapy
- Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
- (2019) Seock-Ah Im et al. NEW ENGLAND JOURNAL OF MEDICINE
- CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
- (2019) Jennifer J Gao et al. LANCET ONCOLOGY
- Vitiligo-like lesions in patients receiving anti–programmed cell death-1 therapies are distinct from spontaneously occurring active vitiligo
- (2018) Katia Boniface et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
- (2018) Debu Tripathy et al. LANCET ONCOLOGY
- Decreased SUMOylation of the retinoblastoma protein in keratinocytes during the pathogenesis of vitiligo
- (2018) Miaoni Zhou et al. Molecular Medicine Reports
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- (2017) Shaimaa Lasheen et al. Expert Review of Anticancer Therapy
- New discoveries in the pathogenesis and classification of vitiligo
- (2017) Michelle Rodrigues et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis
- (2017) Julia Dai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
- (2016) Camille Hua et al. JAMA Dermatology
- Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
- (2015) Hansje-Eva Teulings et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highlights in pathogenesis of vitiligo
- (2015) Ghada F Mohammed World Journal of Clinical Cases
- Alopecia With Endocrine Therapies in Patients With Cancer
- (2013) V. Saggar et al. ONCOLOGIST
- The Requirement for Cyclin D Function in Tumor Maintenance
- (2012) Yoon Jong Choi et al. CANCER CELL
- Targeted cancer therapies
- (2011) Li Yan et al. Chinese Journal of Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now